The influence of therapeutic alliance and insight on medication adherence in schizophrenia
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Poor adherence is one of the leading problems affecting the effectiveness of treatment in schizophrenia. It is an identified factor for relapse and hospitalizations with major social and economic consequences. Various determinants of poor adherence have been identified but few studies investigate the role of therapeutic alliance on medication adherence in routine mental healthcare. AIMS: To investigate links between therapeutic alliance insight and medication adherence in routine care and community psychiatry. METHODS: In this cross-sectional study, 38 inpatients that met ICD-10 criteria for schizophrenia or schizoaffective disorder were recruited and independently interviewed just before discharge. Various rating scales were used: the self-reported 4-Point ordinal Alliance Scale (4PAS), the Medication Adherence Rating Scale (MARS) and the Scale to assess Unawareness of Mental Disorder (SUMD). In addition, we investigated the relationships between medication adherence and clinical variables through uni- and multivariate analysis. RESULTS: Therapeutic alliance was significantly correlated with adherence (r = 0.663, P < 0.0001) and insight (r =-0.664, P < 0.0001). Poor adherence was associated in patients with substance or alcohol use disorders (5.4 vs. 2.9, P = 0.0075, t = 2.83). No significant difference was found between the demographic characteristics of the sample, the characteristics of the treatments and adherence. CONCLUSIONS: A weak therapeutic alliance and low insight are associated with poor adherence in patients with schizophrenia or schizoaffective disorder who were hospitalized. Specific psycho-educational programs to improve therapeutic alliance and insight should be implemented to achieve better therapeutic adherence and outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383
Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.886 · Cited by 621
Frank, A. F. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150028006 · Cited by 552
Mohamed, S., Rosenheck, R., McEvoy, J., Swartz, M., Stroup, S., & Lieberman, J. A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn067 · Cited by 258
Cited by
Sendt, K.-V., Tracy, D. K., & Bhattacharyya, S. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.002 · Cited by 245
Medication nonadherence and psychiatry
Chapman, S. C. E., & Horne, R. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283642da4 · Cited by 142
“Patients with a lack of insight into their psychiatric disorder have also been found to be at risk of nonadherence [13].”
BackgroundNovick, D., Montgomery, W., Treuer, T., Aguado, J., Kraemer, S., & Haro, J. M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0560-4 · Cited by 127
“Another cross-sectional study with 38 inpatients who met ICD-10 criteria for schizophrenia or schizoaffective disorder showed that therapeutic alliance was significantly correlated with adherence and that a weak therapeutic alliance and low insight were associated with poor adherence [13].”
BackgroundLysaker, P. H., Vohs, J., Hillis, J. D., Kukla, M., Popolo, R., Salvatore, G., & Dimaggio, G. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811150 · Cited by 124
Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophrenia
Stevens, G. L., Dawson, G., & Zummo, J. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12278 · Cited by 109
Deng, M., Zhai, S., Ouyang, X., Liu, Z., & Ross, B. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03681-6 · Cited by 75
Vohs, J. L., George, S., Leonhardt, B. L., & Lysaker, P. H. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1199275 · Cited by 66
Tessier, A., Boyer, L., Husky, M., Baylé, F., Llorca, P.-M., & Misdrahi, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.063 · Cited by 64
“Engaging patients in treatment requires an efficient therapeutic alliance (Frank and Gunderson, 1990) which is a key factor in the care of patients with severe psychiatric disorders as it is associated with better adherence (Lecomte et al., 2008; McCabe et al., 2012; Misdrahi et al., 2012).”
BackgroundSelf-citationBrowne, J., Nagendra, A., Kurtz, M., Berry, K., & Penn, D. L. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.05.002 · Cited by 60
Effects of antipsychotic drugs on insight in schizophrenia
Bianchini, O., Porcelli, S., Nespeca, C., Cannavò, D., Trappoli, A., Aguglia, E., De Ronchi, D., & Serretti, A. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.03.022 · Cited by 16
Redefining Medication Adherence in the Treatment of Schizophrenia
Weiden, P. J. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.004 · Cited by 16
“Trust as it pertains to adherence issues is that the treatment recommendation will be congruent with expected outcomes.(28) Although it is essential for the clinician to clearly articulate the benefits of antipsychotic medication for successful treatment, and the importance of staying on continuous antipsychotic thera…”
BackgroundSystematic review of involuntary hospitalisation and long-term compliance
Cossu, G., Gyppaz, D., Kalcev, G., Manca, A. R., Angermeyer, M., Zreik, T., & Carta, M. G. (2023) · International Review of Psychiatry · doi:10.1080/09540261.2022.2119074 · Cited by 13
Metadata
- Authors
- Misdrahi, D., Petit, M., Blanc, O., Bayle, F., & Llorca, P.-M.
- Venue
- Nordic Journal of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2011-08-10
- Volume
- 66
- Issue
- 1
- Pages
- 49-54
- ISSN
- 0029-1455 (ISSN-L)
- 0803-9488
- 1502-4725
- OpenAlex
- W2166106838
- Cited by
- 89
- References
- 7
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.